These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4470269)

  • 21. [Hemodynamics in liver cirrhosis. Hemodynamic peculiarities and possibility of their modification by vasoactive agents in patients with liver cirrhosis].
    Baltzer G
    Fortschr Med; 1973 Feb; 91(6):253-7. PubMed ID: 4806240
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative evaluation of magnetic resonance imaging (MRI) abnormalities in subclinical hepatic encephalopathy.
    Solomou E; Velissaris D; Polychronopoulos P; Kalogeropoulos A; Kiriakopoulou M; Mpadra F; Kordonouri T; Karantza Ch
    Hepatogastroenterology; 2005; 52(61):203-7. PubMed ID: 15783031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy with heparin in active liver cirrhosis (author's transl)].
    Fischer M; Gauss P; Korp W; Nobis H; Schnack H; Weissmann A
    Leber Magen Darm; 1973 Dec; 3(6):253-6. PubMed ID: 4785771
    [No Abstract]   [Full Text] [Related]  

  • 24. [EEG sleep activity in a phenylketonuric child of the 'new variant' type, before and after treatment with 5-HTP and L-DOPA (author's transl)].
    Salomon F; Fagioli I; Rey F; Salzarulo P
    Rev Electroencephalogr Neurophysiol Clin; 1981 Nov; 11(2):212-7. PubMed ID: 7323368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mental state and electroencephalographic picture in liver cirrhosis].
    Stankiewicz D; Mlodzki M; Ekiert H; Jarzebowska E; Gogol Z
    Psychiatr Pol; 1971; 5(6):639-45. PubMed ID: 5160072
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis.
    Lin HC; Hou MC; Lee WC; Huang YT; Lee FY; Chang FY; Tsai YT; Lee SD
    Am J Gastroenterol; 1999 Apr; 94(4):1012-7. PubMed ID: 10201475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlations between psychopathology and EEG patterns in epilepsy (author's transl)].
    Hebenstreit G
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1981 Jun; 12(2):81-3. PubMed ID: 6788533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic and pharmacodynamic aspects of L-DOPA treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in Parkinson's disease (author's transl)].
    García de Yébenes J; Avila C; Bazán E; García E; Gervás J; Maseda C; Mena M; Muradas V; Ramos JA
    Med Clin (Barc); 1982 Apr; 78(7):259-64. PubMed ID: 7087591
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
    Leszek P; Zieliński T; Korewicki J
    Kardiol Pol; 1993 May; 38(5):335-9. PubMed ID: 8366641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of liver cirrhosis. Studies on the hemodynamic effect of xanthinol nicotinate in liver cirrhosis].
    Assheuer J; Boldt I; Schulz D; Winkler C
    Fortschr Med; 1973 Sep; 91(27):1085-8. PubMed ID: 4746762
    [No Abstract]   [Full Text] [Related]  

  • 31. A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis.
    Baruch Y; Assy N; Weisbruch F; Reisner SA; Rinkevich D; Enat R; Blendis LM; Bomzon A
    Am J Gastroenterol; 1999 Oct; 94(10):3000-4. PubMed ID: 10520859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Problems and concepts of psychological lithium Research (author's transl)].
    Kropf D
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Jul; 13(4):168-74. PubMed ID: 7443773
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic disorders due to liver cirrhosis].
    Garbuzenko DV
    Klin Med (Mosk); 1996; 74(2):5-7. PubMed ID: 8772089
    [No Abstract]   [Full Text] [Related]  

  • 34. [Assessment of psychoactivity and long-term efficacy of a retard preparation of oxazepam by blood level determinations and quantitative eeg and psychometric analyses (author's transl)].
    Saletu B; Grünberger J; Linzmayer L; Nitsche V
    Wien Klin Wochenschr; 1978 May; 90(11):382-9. PubMed ID: 664705
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease. The L-dopa era.
    Yahr MD
    Adv Neurol; 1993; 60():11-7. PubMed ID: 8420128
    [No Abstract]   [Full Text] [Related]  

  • 37. Rigid pseudoparkinsonian variant of Huntington's chronic chorea. A case with early onset and the effects of L-dopa treatment.
    Christodorescu D; Costiner E
    Neurol Psychiatr (Bucur); 1979; 17(2):107-11. PubMed ID: 158214
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
    Namba S; Ishimitsu H; Nakasone S
    No To Shinkei; 1980 Oct; 32(10):991-1000. PubMed ID: 6159908
    [No Abstract]   [Full Text] [Related]  

  • 39. [EEG effects of diazepam. Studies on 16 patients (author's transl)].
    Pichlmayr I; Lips U
    Anaesthesist; 1980 Jun; 29(6):317-27. PubMed ID: 7406203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contribution on EEG changes in chronic liver diseases].
    Horký J; Vojtĕchovský M; Blahníková L
    Gastroenterologia; 1967; 108(3):155-63. PubMed ID: 6064100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.